Tags: lunesta | dose | sleeping | pill

FDA Cuts Sleeping Pill Dosage

Thursday, 15 May 2014 04:43 PM

U.S. health regulators on Thursday said they required a label change for the sleep drug Lunesta to cut the recommended starting dose over concerns it could impair alertness in some people the following morning.

The Food and Drug Administration said the starting dose for the drug taken at bedtime for both men and women should be the lowest 1 milligram dose, down from the previous 2 mg recommended starting dose. The agency said the drug could remain in a patient's system long enough to impair activities such as driving, even if the person feels fully awake.

"To help ensure patient safety, health care professionals should prescribe, and patients should take, the lowest dose of a sleep medicine that effectively treats their insomnia," Ellis Unger, of the FDA's Center for Drug Evaluation and Research, said in a statement.

The 1 mg dose can be increased to 2 mg or 3 mg if needed, but the higher doses are more likely to result in next-day impairment, the agency said.

Lunesta is sold by the Sunovion Pharmaceuticals unit of Japanese drugmaker Dainippon Sumitomo Pharma Co.
 
The label change decision was made after a study showed Lunesta 3 mg was associated with severe next-morning psychomotor and memory impairment in both men and women.

The study found that the higher doses can cause impairment to driving skills, memory and coordination as long as 11 hours after the drug is taken, with little awareness of the impairment on the part of the patient.

© 2017 Thomson/Reuters. All rights reserved.

 
1Like our page
2Share
Health-News
U.S.health regulators on Thursday said they required a label change for the sleep drug Lunesta to cut the recommended starting dose over concerns it could impair alertness in some people the following morning.The Food and Drug Administration said the starting dose for the drug...
lunesta, dose, sleeping, pill
247
2014-43-15
Thursday, 15 May 2014 04:43 PM
Newsmax Inc.
 

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved